198
R.A. Watile et al. / Journal of Molecular Catalysis A: Chemical 351 (2011) 196–203
13C NMR (100 MHz, CDCl3) 158.06, 139.07, 129.03, 128.89,
125.63, 74.44, 52.30, 44.34, 31.53, 27.45, 26.6, 22.6, 14.12.
GC–MS (EI) m/z (%) = 247(42) [M]+, 156(21.0), 132(100),
104(53.0), 43(36.0).
PerkinElmer FT-IR spectrophotometer with anhydrous KBr as stan-
dard (Thermo Electron Co.). The amount of diol functionalized
ILs attached on the (chloromethyl polystyrene resin) CMPS was
determined by elemental analysis (Thermo finnigan) PS-DHPIMBr
(loading, 3.2 mmol/g), PS-DHEIMCl (loading, 2.8 mmol/g). Solid-
state NMR was carried out for 13C nuclei. Thermo gravimetric
analysis (TGA) was carried out using TGA-SDT (Q600 V8.2 Build
100) in a nitrogen atmosphere between 25 ◦C and 600 ◦C at a heat-
ing rate 5 ◦C/min.
(v) 3-Cyclohexyl-5-phenyloxazolidin-2-one (Table 1, entry 10)
1H NMR (300 MHz, DMSO-d6) ı = 7.31–7.46 (m, 5H), 5.53
(dd, J = 8.7, 72 Hz, 1H), 3.92 (t, J = 8.9 Hz, 1H), 3.57 (m, 1H),
3.26 (m, 1H), 0.91–1.94 (m, 10H).
GC–MS (EI) m/z (%) = 245.90(12.7) [M+1]+, 245(67) [M]+,
201(18), 163(37), 157(35), 120(38), 104(100), 91(65.0),
55(80), 45(84), 41(57).
2.4. General procedure for carboxylation of aziridines with CO2
(vi) 3-Butyl-5-(4-(tert-butyl) phenyl) oxazolidin-2-one (Table 1,
entry 12)
In a typical experimental procedure, coupling of aziridines with
CO2 was carried out in a 100 mL stainless steel autoclave reac-
tor with a mechanical stirrer. Aziridine (1 mmol) and catalyst
(1.5 mol %) were charged into the reactor at room temperature.
CO2 gas was introduced into the autoclave and then pressure was
adjusted to desired pressure (5 MPa) and the mixture was stirred
(550–600 rpm) continuously at room temperature for mentioned
time period. On completion of reaction, the reactor was cooled
in ice-water and CO2 was ejected slowly. The reaction mixture
was analyzed by GC (PerkinElmer, Clarus 400) equipped with a
flame ionization detector (FID) and a capillary column (Elite-1,
30 m × 0.32 mm × 0.25 m). The residue was purified by column
ether/ethyl acetate) to afford the product. The products further ana-
lyzed by 1H and 13C spectra recorded on NMR spectrometer (Varian
300) using TMS as internal standard and by GC–MS (Shimadzu QP
2010) which are consistent with those reported in the literature
[24–27].
1H NMR (300 MHz, DMSO-d6) ı = 7.41–7.46 (m, 4H), 5.47
(m, 1H), 3.91 (t, J = 8.9 Hz, 1H), 3.39 (dd, J = 8.9, 7.4 Hz, 1H),
0.93 (m, 3H).
(vii) 5-Phenyloxazolidin-2-one (Table 1, entry 1)
GC–MS (EI) m/z (%) = 162.96(16) [M]+, 107(100), 91(13),
89(15), 45(31).
(viii) 3-Methyl-5-phenyloxazolidin-2-one (Table 1, entry 2)
GC–MS (EI) m/z (%) = 177(4) [M]+, 176(29.40), 133(24.6),
132(55), 91(23), 85(10.7), 43(100).
2.5.2. Characterization of aziridines
(i) 1-Methyl-2-phenylaziridine (Table 1, entry 2)
1H NMR (300 MHz, DMSO-d6) ı = 7.07–7.39 (m, 5H), 2.37
(m, 3H), 2.24 (m, 1H), 1.72 (d, J = 3.4 Hz, 1H), 1.61 (d, J = 6.4 Hz,
1H).
GC–MS (EI) m/z (%) = 133(10) [M]+, 132(100), 91(39),
42(12).
(ii) 1-Butyl-2-phenylaziridine (Table 1, entry 6)
7.23–7.30 (m, 3H), 2.31–2.54 (m, 3H), 1.88 (d, J = 2.3 Hz, 1H),
1.17 (d, J = 6.4 Hz, 1H), 1.31–1.61 (m, 4H), 0.99 (m, 3H).
GC–MS (EI) m/z (%) = 175.90(12) [M]+, 174(72.8), 132(100),
133(30), 118(73.8), 98(45.5), 91(97.5), 65(14.1).
(iii) 1-Ethyl-2-phenylaziridine (Table 1, entry 3)
GC–MS (EI) m/z (%) = 147(12.5) [M]+, 146(100), 118(25),
91(88), 77(11.3), 65(15.7).
(iv) 2-Phenyl-1-propylaziridine (Table 1, entry 4)
GC–MS (EI) m/z (%) = 161(8.6) [M]+, 160(62.60), 118(47.7),
91(100), 65(10.7).
(v) 1-Tert-butyl-2-phenylaziridine (Table 1, entry 9)
GC–MS (EI) m/z (%) = 175(6.8) [M]+, 174(34.1), 118(100),
91(94.5), 57(18.3), 41(15.0).
(vi) 1-Hexyl-2-phenylaziridine (Table 1, entry 7)
GC–MS (EI) m/z (%) = 203(21.8) [M]+, 132(50.4), 126(26.6),
117(31.6), 114(19.6), 91(46.4), 86(23.7), 73(55.9), 72(66.9),
44(70.8), 43(100).
(vii) 1-Cyclohexyl-2-phenylaziridine (Table 1, entry 11)
GC–MS (EI) m/z (%) = 201(16.4) [M]+, 200(68.4), 174(10),
119(14.6), 118(100), 91(96), 55(21.4), 41(18.3).
(viii) 1-Butyl-2-(4-(tert-butyl) phenyl) aziridine (Table 1, entry 12)
GC–MS (EI) m/z (%) = 231(3.8) [M]+, 230(26.5), 229.95(94.7),
215(10), 187(94.7), 188(36.4), 160(41.5), 132(83.3),
118(53.0), 117(39.5), 98(56), 57(100), 41(50).
2.5. Spectral data of selected products
2.5.1. Characterization of oxazolidinones
(i) 3-Ethyl-5-phenyloxazolidin-2-one (Table 1, entry 3)
1H NMR (300 MHz, DMSO-d6) ı = 7.34–7.65 (m, 5H), 5.51
(m, 1H), 3.93 (t, 1H), 3.43 (t, 1H), 3.15 (m, 2H), 1.15 (t, 3H).
126.9, 69.72, 51.15, 38.73, 12.41.
GC–MS (EI) m/z (%) = 191(55.0) [M]+ 175(7.9), 146(39),
132(22), 105(22.2), 91(43.2), 77(22.1), 65(14), 57(100),
42(57.9).
(ii) 5-Phenyl-3-propyloxazolidin-2-one (Table 1, entry 4)
1H NMR (300 MHz, DMSO-d6) ı = 7.34–7.65 (m, 5H), 5.52
(m, 1H), 3.92 (m, 1H), 3.32 (m, 1H), 3.26 (m, 2H), 1.57 (m, 2H),
0.91 (m, 3H).
125.59, 69.93, 52.23, 45.09, 20.75, 11.18.
GC–MS (EI) m/z (%) = 205(7.2) [M]+, 204(51.0), 114(13),
132(100), 117(15), 105(41.0), 91(29.0), 70(38), 43(43),
42(33).
(iii) 3-Butyl-5-phenyloxazolidin-2-onen (Table 1, entry 6)
1H NMR (300 MHz, DMSO-d6) ı = 7.33–7.46 (m, 5H), 5.51
(m, 1H), 3.94 (t, J = 8.9 Hz, 1H), 3.41 (t, 1H), 3.19 (t, J = 7.0,
4.3 Hz, 2H), 1.40 (m, 2H), 1.29 (d, J = 7.6 Hz, 2H), 0.79–0.95
(m, 3H).
125.60, 74.42, 52.25, 44, 29.49, 19.93, 13.79.
GC–MS (EI) m/z (%) = 219(55.7) [M]+, 133(10.0), 134(100),
117(13.7), 105(37.4),103(30.0), 91(20.3), 84.5(25.7), 78(10).
(iv) 3-Hexyl-5-phenyloxazolidin-2-one (Table 1, entry 7)
1H NMR (300 MHz, DMSO-d6) ı = 7.33–7.45 (m, 5H), 5.55
(dd, J = 8.7, 7.2 Hz, 1H), 3.94 (t, J = 8.7 Hz, 1H), 3.41 (m, 1H),
3.18 (td, J = 7.1, 2.1 Hz, 2H), 1.47 (t, J = 6.8 Hz, 2H), 1.12–1.35
(m, 6H), 0.77–0.93 (m, 3H).
2.5.3. Catalyst reusability
The reaction was carried out as mentioned above in typical
experimental procedure. After completion of reaction, the reaction
mixture was cooled to room temperature and the insoluble cata-
lyst was recovered by filtration technique. It was then thoroughly
washed with acetone to remove all traces of product or reactant
if present and was dried in oven at 80–85 ◦C for 1 h. It was then